52 institutional investment managers reported SGP positions in their Form 13F filings for Q2 2026, holding 26,122,891 shares worth $581M in total. Ra Capital Management, L.p. reported the largest position.

Are funds buying or selling SGP?

In Q2 2026, 22 managers opened new SGP positions, 17 added, 5 trimmed and 5 sold out. Managers that filed in both quarters added a net 769,500 shares.

How current is this SGP institutional ownership data?

It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Funds · SGP

Who owns SGP?

Institutional ownership of SpyGlass Pharma Inc. from Form 13F, Q2 2026

52 institutional managers reported holding SpyGlass Pharma Inc. (SGP) in Form 13F filings for Q2 2026, with 26,122,891 shares worth $581M. The largest reported holder was Ra Capital Management, L.p. Managers that filed both quarters added a net 769,500 shares (+3.0%). 22 opened new positions and 5 sold out.

Funds holding: 52
Value held: $581M
New / sold out: 22 / 5
Net shares, same filers: +3.0%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of SGP

Fund	Value	Share of 13F holdings	Shares	Move
Ra Capital Management, L.p.	$179M	30.7%	8,021,117	Unchanged
NEA Management Company, LLC	$165M	28.3%	7,392,301	Unchanged
Sands Capital Alternatives, LLC	$55.7M	9.6%	2,500,012	Unchanged
Samsara Biocapital, LLC	$47.0M	8.1%	2,109,953	Unchanged
BlackRock, Inc.	$15.8M	2.7%	711,712	Added
Price T Rowe Associates Inc	$15.0M	2.6%	674,143	Trimmed
Vestal Point Capital, LP	$14.9M	2.6%	670,000	Added
JPMorgan Chase & Co	$13.6M	2.4%	629,739	Added
Deerfield Management Company, L.p.	$12.2M	2.1%	550,000	Unchanged
Millennium Management LLC	$11.3M	1.9%	507,257	Added
Aberdeen Group plc	$11.0M	1.9%	493,076	Added
Vanguard Capital Management LLC	$9.7M	1.7%	434,423	Unchanged
Geode Capital Management, LLC	$6.2M	1.1%	277,325	Added
Franklin Resources Inc	$5.2M	0.9%	233,412	Trimmed
Affinity Asset Advisors, LLC	$2.9M	0.5%	131,586	Trimmed
State Street Corp	$2.6M	0.5%	117,561	Added
Charles Schwab Investment Management Inc	$1.9M	0.3%	85,681	Added
Northern Trust Corp	$1.8M	0.3%	82,451	Added
Vanguard Portfolio Management LLC	$1.7M	0.3%	75,812	Added
Vanguard Fiduciary Trust Co	$1.5M	0.3%	68,498	Added
Alyeska Investment Group, L.P.	$1.3M	0.2%	57,000	Unchanged
TD Asset Management Inc	$1.1M	0.2%	47,580	Unchanged
Ameriprise Financial Inc	$1.0M	0.2%	45,668	Added
Alps Advisors Inc	$755K	0.1%	33,932	New
Bank of New York Mellon Corp	$533K	0.1%	23,944	New

Share of 13F holdings is each fund's shares as a share of the 26,122,891 SGP shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

BlackRock, Inc. Added+$12.6M
Aberdeen Group plc Added+$6.1M
Geode Capital Management, LLC Added+$3.4M
State Street Corp Added+$2.2M
Vanguard Portfolio Management LLC Added+$1.6M
Northern Trust Corp Added+$1.4M
JPMorgan Chase & Co Added+$1.1M
Millennium Management LLC Added+$856K
Alps Advisors Inc New+$755K
Charles Schwab Investment Management Inc Added+$580K

Biggest sellers in Q2 2026

First Light Asset Management, LLC Sold out-$9.7M
Affinity Asset Advisors, LLC Trimmed-$2.6M
Monashee Investment Management LLC Sold out-$2.5M
Franklin Resources Inc Trimmed-$1.5M
Marshall Wace, LLP Sold out-$760K
Price T Rowe Associates Inc Trimmed-$674K
Goldman Sachs Group Inc Sold out-$500K
Bank of America Corp Trimmed-$374K
Squarepoint Ops LLC Sold out-$202K
Vanguard Capital Management LLC Unchanged-$9K

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $34.0M and sold $18.8M; 17 added and 5 trimmed.

Schedule 13D and 13G filings on SGP

Owners of more than 5% must file within days, so these can be newer than the 13F data.

2026-02-18Samsara BioCapital, L.P. SCHEDULE 13G filed by SpyGlass Pharma Inc.Schedule 13G
2026-02-18RA CAPITAL MANAGEMENT, L.P. SCHEDULE 13D filed by SpyGlass Pharma Inc.Schedule 13D
2026-02-13New Enterprise Associates 17, L.P. SCHEDULE 13D filed by SpyGlass Pharma Inc.Schedule 13D
2026-02-13Gilde Healthcare Holding B.V. SCHEDULE 13D filed by SpyGlass Pharma Inc.Schedule 13D

Questions about SGP ownership

Who owns SGP stock?: 52 institutional investment managers reported SGP positions in their Form 13F filings for Q2 2026, holding 26,122,891 shares worth $581M in total. Ra Capital Management, L.p. reported the largest position.
Are funds buying or selling SGP?: In Q2 2026, 22 managers opened new SGP positions, 17 added, 5 trimmed and 5 sold out. Managers that filed in both quarters added a net 769,500 shares.
How current is this SGP institutional ownership data?: It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to SGP by CUSIP. Options are left out. SGP news and filings · SGP insider trades · Top funds